We are excited to announce that last month, The Miller McNeil Woodruff Foundation made a $10,000 donation to FSMA. This donation will help fund the $160,000 basic research grant that FSMA awarded Dr. Henderson of Columbia University:
Newly Funded Spinal Muscular Atrophy Researcher Profile at Families of SMA: Dr. Christopher Henderson.
November 7, 2011.

Dr. Henderson is a Professor at Columbia University and has been awarded a basic research grant for $160,000 from Families of SMA.
Who are you?
I am a neuroscientist interested in motor neurons, what allows them to develop normally and what triggers their degeneration in diseases like SMA and ALS. Click here to see the Henderson lab website.
How did you first become involved with SMA research?
When I was still a postdoctoral fellow in Paris, France, I collaborated with Dr. Michel Fardeau, one of the real experts on the disease. We showed in 1987 that muscle biopsies from SMA patients – which were then taken routinely for diagnosis – contain factors that prevent nerve regrowth. This was my first introduction to working with clinicians to understand disease mechanisms and I have tried to continue ever since.
What is your current role in SMA research?
My lab focuses on defining potential therapeutic targets in SMA. This requires studying the disease process in mouse models and attempting to define molecular events that, when prevented, will confer benefit. My recent partnership with Dr. Hynek Wichterle in co-directing the Project A.L.S Laboratory for Stem Cell Research, and our collaboration with Dr. Kevin Eggan at Harvard, has given us access to human motor neurons with the same genetic makeup as the patients. I am also one of the co-directors of the Motor Neuron Center at Columbia University, which brings together 40 groups working on motor neuron biology and disease, and which houses 15 groups working directly on SMA.
Description of FSMA-funded project.
Stem Cell Models of SMA: Molecular and Cellular Mechanisms, $160,000 for 2 years.
Objective: One of the main challenges in understanding SMA is determining how the lack of a precise protein, SMN, found in all the cells of the body primarily affects motor neurons. The objective of this project is to establish and characterize human cellular models of the disease “in a dish” and to use these models to determine the molecular pathways affected.
Research Strategy: This team will develop unique new tools, using human stem cells carrying the genetic mutation responsible for SMA, which can be differentiated in vitro into any kind of specific cell type of the human organism. In this case, they will be turned into motor neurons. They will be used to generate a series of SMA motor neurons with differing levels of SMN protein and then characterized both at the morphological and molecular level, in order to better understand the pathological of the disease. Thus the project will generate a highly valuable set of tools for studies of SMA pathology in a dish.
Significance of Project: Even though the biological cause of SMA in humans has been identified and animal models of the disease have been developed, remarkably little is known about the cellular and molecular mechanisms that lead to the specific loss of motor neurons in the human patients. The use of this unique set of tools will help us to answer these questions and to lead to new targets for therapeutic strategies for SMA.














